REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".

NCT07390214 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-02-05

No results posted yet for this study

Summary

This is a prospective, randomized (1:1), pilot study enrolling 200 patients with symptomatic atrial fibrillation or atrial tachycardia (AF/AT) recurrence requiring repeat ablation following a single prior PVI procedure for AF.

Conditions

  • Atrial Fibrillation - Symptomatic

Interventions

PROCEDURE

Dual Energy ablation with RF/PFA: Re-PVI and substrate modification of low voltage areas

Re-PVI

PROCEDURE

CF-guided RFC: Re-PVI and substrate modification of low voltage areas

Re-PVI

Sponsors & Collaborators

  • Cardioangiologisches Centrum Bethanien

    lead OTHER

Principal Investigators

  • Julian Chun, Professor · MVZ CCB Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2028-06-30
Completion
2029-03-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07390214 on ClinicalTrials.gov